Medifast Inc

  • Earnings Score
  • Moat Score
  • Market Cap $142.65M
  • PE -20
  • Debt -
  • Cash $91.72M
  • EV -
  • FCF $13.47M

Earnings

loading chart...

Sales & Net Margins

loading chart...
Earnings-$7.00M
EBIT-$7.27M
ROE-3%
ROA-3%
FCF$13.47M
Equity$210.96M
Growth Stability2%
PE-20.39
PEG0.53
PB0.68
P/FCF10.59
P/S0.26
Price/Cash0.64
Net Margins-1%
Gross Margins74%
Op. Margins-1%
Earnings CAGR10%
Sales Growth YoY-34%
Sales Growth QoQ-3%
Sales CAGR19%
FCF CAGR10%
Equity CAGR11%
Earnings Stability0.06
Earnings Growth YoY-109%
Earnings Growth QoQ-196%
Earnings CAGR 5Y-39%
Sales CAGR 5Y-9%
FCF CAGR 5Y-25%
Equity CAGR 5Y8%
Earnings CAGR 3Y-36%
Sales CAGR 3Y-36%
FCF CAGR 3Y-54%
Equity CAGR 3Y18%
Market Cap$142.65M
Revenue$543.45M
Dividend Yield0%
Payout Ratio-3%
Assets$280.01M
Cash$91.72M
Shares Outstanding10.95M
Earnings Score7%
Moat Score16%
Working Capital152.93M
Current Ratio3.52
Gross Profit$401.58M
Shares Growth 3y0%
Equity Growth QoQ0%
Equity Growth YoY-0%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...
Medifast Inc is a US-based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. The company generates its revenue from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other consumable health and nutritional products.

SEC Filings

Direct access to Medifast Inc (MED) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

  • 2025
    • 10-Q Mar 31
  • 2024
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2023
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31

Sector Comparison

How does Medifast Inc compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Medifast Inc compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR 10%
Stability 6%
loading chart...

Medifast Inc Discounted Cash Flow

Fully customizable DCF calculator online for Medifast Inc.

= $274M
012345678910TV
fcf$13M$15M$16M$18M$20M$22M$24M$27M$29M$32M$36M$358M
DCF$13M$14M$14M$14M$14M$14M$14M$14M$14M$14M$138M
Value$274M

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years12/201512/201612/201712/201812/201912/202012/202112/202212/202312/2024TTM
Net Margins7%6%9%11%11%11%11%9%9%0%-1%
ROA-23%28%42%48%49%54%58%42%1%-3%
ROE-19%26%51%74%65%81%93%49%1%-3%

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years12/201512/201612/201712/201812/201912/202012/202112/202212/202312/2024TTM
Debt over FCF-----------
Debt over Equity-----------
Growth Stability---100%100%100%100%100%73%2%2%

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years12/201512/201612/201712/201812/201912/202012/202112/202212/202312/2024CAGR 5Y
Revenue YoY growth-1%10%66%42%31%63%5%-33%-44%-9%
Earnings YoY growth--11%55%101%40%32%59%-12%-31%-98%-39%
Equity YoY growth-8%13%0%-4%50%29%-23%30%4%8%
FCF YoY growth--24%73%40%33%88%-57%195%-21%-88%-25%